BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 9207804)

  • 1. Predictors of bone mineral loss in patients with ovarian cancer treated with anticancer agents.
    Douchi T; Kosha S; Kan R; Nakamura S; Oki T; Nagata Y
    Obstet Gynecol; 1997 Jul; 90(1):12-5. PubMed ID: 9207804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of upper body fat distribution to higher regional lean mass and bone mineral density.
    Matsuo T; Douchi T; Nakae M; Uto H; Oki T; Nagata Y
    J Bone Miner Metab; 2003; 21(3):179-83. PubMed ID: 12720053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in the relative contribution of lean and fat mass components to bone mineral density with generation.
    Mizuma N; Mizuma M; Yoshinaga M; Iwamoto I; Matsuo T; Douchi T; Osame M
    J Obstet Gynaecol Res; 2006 Apr; 32(2):184-9. PubMed ID: 16594922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between body composition and bone mineral density in healthy premenopausal women].
    Liu JM; Zhao HY; Ning G; Zhang LZ; Xu MY; Chen JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):250-3. PubMed ID: 12905733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.
    Vehmanen L; Elomaa I; Blomqvist C; Saarto T
    J Clin Oncol; 2006 Feb; 24(4):675-80. PubMed ID: 16446340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between body composition and bone mineral density (BMD) in perimenopausal Korean women.
    Kim CJ; Oh KW; Rhee EJ; Kim KH; Jo SK; Jung CH; Won JC; Park CY; Lee WY; Park SW; Kim SW
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):18-26. PubMed ID: 19178508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precedence of the shift of body-fat distribution over the change in body composition after menopause.
    Morita Y; Iwamoto I; Mizuma N; Kuwahata T; Matsuo T; Yoshinaga M; Douchi T
    J Obstet Gynaecol Res; 2006 Oct; 32(5):513-6. PubMed ID: 16984520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer.
    Gordon AM; Hurwitz S; Shapiro CL; LeBoff MS
    Menopause; 2011 Nov; 18(11):1244-8. PubMed ID: 21814159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body composition, bone mineral density, and circulating leptin levels in postmenopausal Turkish women.
    Sahin G; Polat G; Baethiş S; Milcan A; Baethdatoethlu O; Erdoethan C; Camdeviren H
    Rheumatol Int; 2003 Mar; 23(2):87-91. PubMed ID: 12634942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative contribution of lean and fat mass component to bone mineral density in males.
    Douchi T; Kuwahata R; Matsuo T; Uto H; Oki T; Nagata Y
    J Bone Miner Metab; 2003; 21(1):17-21. PubMed ID: 12491089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
    Perez EA; Josse RG; Pritchard KI; Ingle JN; Martino S; Findlay BP; Shenkier TN; Tozer RG; Palmer MJ; Shepherd LE; Liu S; Tu D; Goss PE
    J Clin Oncol; 2006 Aug; 24(22):3629-35. PubMed ID: 16822845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline bone mineral density of the total lumbar spine may predict for chemotherapy-induced ovarian failure.
    Shapiro CL; Phillips G; Van Poznak CH; Jackson R; Leboff MS; Woodard S; Lemeshow S
    Breast Cancer Res Treat; 2005 Mar; 90(1):41-6. PubMed ID: 15770525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.
    Galvão DA; Spry NA; Taaffe DR; Newton RU; Stanley J; Shannon T; Rowling C; Prince R
    BJU Int; 2008 Jul; 102(1):44-7. PubMed ID: 18336606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain.
    Yano S; Sugimoto T; Tsukamoto T; Yamaguchi T; Hattori T; Sekita KI; Kaji H; Hattori S; Kobayashi A; Chihara K
    Horm Metab Res; 2003 Apr; 35(4):259-64. PubMed ID: 12778370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-weight-bearing effect of trunk and peripheral fat mass on bone mineral density in pre- and post-menopausal women.
    Kuwahata A; Kawamura Y; Yonehara Y; Matsuo T; Iwamoto I; Douchi T
    Maturitas; 2008; 60(3-4):244-7. PubMed ID: 18774244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment.
    Briot K; Gossec L; Kolta S; Dougados M; Roux C
    J Rheumatol; 2008 May; 35(5):855-61. PubMed ID: 18381782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal weight and lean body mass may influence the lactation-related bone changes in young undernourished Indian women.
    Kulkarni B; Shatrugna V; Nagalla B; Ajeya Kumar P; Usha Rani K; Chandrakala Omkar A
    Br J Nutr; 2009 May; 101(10):1527-33. PubMed ID: 18959808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
    van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.